Treatment with Justicia secunda and aspirin improved biomarkers and oxidative stress in male Wistar rats following myocardial infarction, indicating potential therapeutic benefits.
Background: Myocardial infarction is an increasing cardiac disorder globally. This study investigated the ameliorative potentials of Justicia secunda hydromethanol leaf extract on epinephrine-induced myocardial infarction in male Wistar rats. Methods: Twenty-four rats weighing (70-170 gm) were assigned into 6 groups (n=4). Group A was control, group B received epinephrine (0.08 mg/kg) intraperitoneally for 2 days; groups C-F received epinephrine followed by oral treatments: Aspirin (2 mg/kg), Justicia secunda (1 mg/kg), Justicia secunda (2 mg/kg) and vitamin C (2 mg/kg) respectively for 14 days. Results: There was a significant elevation of lactate dehydrogenase and troponin T and disruption in electrolyte balance, indicative of myocardial injury. Treatment with Justicia secunda (2 mg/kg), aspirin, and vitamin C significantly reduced LDH and troponin T levels (p<0.01), improved antioxidant status (increased SOD, CAT, GSH; decreased MDA), and slightly normalized electrolytes. Justicia secunda (2 mg/kg), exhibited improvement in high-density-lipoproteins and reduction in low-density-lipoprotein levels. Conclusions: Treatment with Justicia secunda (particularly at 2 mg/kg), aspirin, and vitamin C ameliorated the epinephrine-induced myocardial infarction. Hence, if these results apply to humans, using Justicia secunda in management of myocardial infarction and oxidative stress should be encouraged as a potential natural adjunct.
No takes yet. Share an insight, caveat, or question.
Mobisson et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: